TGIA
PFE icon

Torrey Growth & Income Advisors’s Pfizer PFE Stock Holding History

Torrey Growth & Income Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.34M Sell
304,431
-28,236
-8% -$739K 2.49% 9
2026
Q1 		$9.35M Buy
332,667
+18,667
+6% +$497K 3.92% 4
2025
Q4 		$7.82M Buy
314,000
+143,958
+85% +$3.63M 2.72% 8
2025
Q3 		$4.33M Buy
+170,042
New +$4.2M 1.28% 15

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Torrey Growth & Income Advisors's PFE Position: Q2 2026 in Review

Torrey Growth & Income Advisors reduced its Pfizer (PFE) stake by 8.5% in Q2 2026, selling an estimated $739K and leaving 304,431 shares worth $7.34M. The position accounts for 2.49% of the portfolio, ranked #9.

Torrey Growth & Income Advisors first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.35M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Torrey Growth & Income Advisors held 304,431 shares of Pfizer worth $7.34M as of Q2 2026.
  • Torrey Growth & Income Advisors sold 28,236 Pfizer shares in Q2 2026, an estimated $739K.
  • Pfizer made up 2.49% of Torrey Growth & Income Advisors's portfolio in Q2 2026, its #9 holding.
  • Torrey Growth & Income Advisors first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
  • Torrey Growth & Income Advisors's Pfizer position peaked at $9.35M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Torrey Growth & Income Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.